NR3C1 and neuroblastoma: To test the impact of GCs on PRV infection in neuron-like cells, Neuro-2A cells (mouse neuroblastoma cells) were infected with PRV (multiplicity of infection of 1, MOI = 1) and treated or not with the GR agonist DEX (10 μM).